Mohamad is a General Partner and heads NEA’s Healthcare Services and Healthcare Information Technology investment practice. Mohamad first joined NEA as an intern in 2000 and later as an associate in 2005. He is currently a Director of Aetion, American Pathology Partners, Bright Health, Collective Health, Curisium, Nuvolo, Paladina Health, Radiology Partners, SCI Solutions, Strive Health, and Welltok. Mohamad’s past investments include Bravo Health, CHG Healthcare, DaVita NephroLife, DSI Renal, Golden State Medical Supply, Long Term Care Group, ppoNEXT, U.S. Renal Care, and Vantage Oncology.

Previously, Mohamad focused on growth equity investments at Summit Partners prior to which he worked with UBS Investment Bank where he concentrated on leveraged finance and sponsor-led transactions. Mohamad received a bachelor's degree, with distinction, from the University of Pennsylvania; he is an active participant in the cancer community having been a founding board member of Livestrong’s Young Leadership Cancer Council and a board member of The National Venture Capital Association (NVCA).